Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. Biopharmaceutical firm Retrophin Inc. (RTRX:NASDAQ) shares are trading much lower today as the co...
Streetwise Reports | August 26, 2019 |

Buzz on the Bullboards: Do you have these stocks in your portfolio?

This past week, the TSX has been riding a wave of optimism, buoyed by expectations of potential interest-rate cuts in the United States. However, the index recently snapped an impressive eight-session winning streak after data revealed that Canada’...
Jonathon Brown | August 22, 2024 |

ChemoCentryx Shares Spike 300% on Phase 3 ANCA Vasculitis Trial Results

Shares of ChemoCentryx Inc. opened greater than 330% higher today after the firm reported positive topline data from its pivotal Phase 3 ADVOCATE trial of Avacopan in treatment of ANCA-associated vasculitis. After the U.S. markets closed yesterday, ChemoCentryx Inc. ...
Streetwise Reports | November 27, 2019 |

Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data

Shares of Aurinia Pharmaceuticals traded much higher today after it reported positive results from its Phase 3 AURORA trial of Voclosporin for treatment of lupus nephritis. The company plans to submit a New Drug Application to the FDA in H1/20. Yesterday afternoon, Vi...
Streetwise Reports | December 7, 2019 |

International stocks with serious potential

This week we'll take a closer look at some actual stocks and country-related ETFs you can buy that capitalize on the strength of the country itself and that of its underlying currencies. To help clarify what we looked at last week, here's two currency charts featuring the ...
Nick Thomas | October 28, 2012 |

Buzz on the Bullboards: The top stocks in energy, mining and EVs

As investors navigate through another week of market activity, attention remains divided between Toronto and New York, with corporate earnings and a significant U.S. Federal Reserve monetary policy decision dominating discussions. In Toronto, the TSX experienc...
Jonathon Brown | May 2, 2024 |

Reata Pharma Shares Trading Higher After Reacquiring U.S. and Worldwide Licensing Rights

Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie. Clinical-stage...
Streetwise Reports | October 15, 2019 |

April 15th 2020, Crypto Chartbook: Evolve or die

Evolve or die That might be too strong a title, but it’s not! The law of evolution is principle based, saying that adoption is required especially in times of rapid change. It is without a question such a time. For example, a successful carburetor spe...
Korbinian Koller | April 15, 2020 |

Common Stock Warrants Are a Powerful Wealth Building Tool with Dudley Baker

I recently did this interview with Kerry Lutz and we walk through investment possibilities with mining shares and stock warrants. There is a short advertising break in the middle, so don't leave the interview until completed. Common Stock Warrants Are a Powerful ...
Dudley Pierce Baker | January 30, 2020 |

Getchell Gold’s Nevada Projects Offer Serious Upside

Getchell Gold offering loads of upside at its Fondaway Canyon gold and Star Point copper-gold projects in Nevada Identifying the opportunity in an undervalued project is where that “sweet spot” of resource investing comes in - purchasing an underval...
Richard (Rick) Mills | November 9, 2020 |
1 2 3 4 5 6 7 8 9 10 ...